L26/O-032 Clinical outcomes following non-invasive preimplantation genetic testing in IVF: A systematic review and meta-analysis
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.032 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von A.N. Kovilveettil und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Among women undergoing IVF, does embryo selection using non-invasive preimplantation genetic testing (niPGT) improve live birth and other clinical outcomes compared with conventional embryo selection? Summary answer niPGT was associated with higher cumulative live birth and clinical pregnancy rates compared with morphology-based selection in one large cohort, but evidence remains limited. What is known already niPGT analyses embryonic cell-free DNA from spent culture medium or blastocoel fluid, avoiding embryo biopsy. While diagnostic accuracy studies have demonstrated variable concordance with trophectoderm biopsy, the impact of niPGT on clinically meaningful outcomes such as live birth remains uncertain. Most published studies focus on laboratory performance rather than reproductive outcomes, and there is no consensus on whether niPGT improves IVF success compared with conventional embryo selection or invasive PGT-A. Study design, size, duration This systematic review followed a pre-registered PROSPERO protocol. Electronic databases were searched from inception to January 2026. Comparative and non-comparative clinical studies reporting reproductive outcomes following niPGT were included. Eight eligible studies were identified, comprising prospective and retrospective cohort studies and approximately 2,000 embryo transfers. Participants/materials, setting, methods Participants were women or couples undergoing IVF/ICSI with embryo selection using niPGT, with or without conventional morphology or morphokinetics. Comparators included morphology-based selection, ICSI without PGT, or trophectoderm PGT-A. The primary outcome was live birth, including cumulative live birth where reported. Secondary outcomes included clinical pregnancy, ongoing pregnancy, miscarriage, and implantation. Due to heterogeneity, results were synthesised narratively, with limited 2 × 2 analyses performed. Main results and the role of chance Only three studies reported live birth outcomes, and only one large three-armed prospective cohort provided data suitable for comparative effect estimation. In women aged 35–40 years, niPGT was associated with a higher cumulative live birth rate compared with morphology-based embryo selection (odds ratio [OR] 2.10, 95% CI 1.28–3.43). Clinical pregnancy rates were also higher with niPGT (OR 1.75, 95% CI 1.08–2.84). Per-transfer analyses showed similar effect sizes for live birth (OR 2.26, 95% CI 1.35–3.80) and clinical pregnancy (OR 1.85, 95% CI 1.11–3.11). In the same cohort, cumulative live birth and clinical pregnancy rates did not differ significantly between niPGT and trophectoderm PGT-A (OR for cumulative live birth 0.78, 95% CI 0.45–1.36). Other studies reported improvements in pregnancy outcomes in selected populations, including advanced maternal age, recurrent pregnancy loss, and mosaic embryo transfer, but lacked appropriate comparators. Meta-analysis across studies was not feasible due to substantial clinical and methodological heterogeneity. Limitations, reasons for caution Evidence is limited by few comparative studies reporting live birth, heterogeneous populations and interventions, inconsistent outcome definitions, and absence of randomized controlled trials powered for clinical outcomes. Wider implications of the findings niPGT may improve cumulative live birth and pregnancy outcomes compared with conventional embryo selection in selected IVF populations, but robust randomized trials are required before routine clinical adoption. Trial registration number Yes
Zitieren
APA
Kovilveettil, A., Abdulah, A., Bailie, E., & Jayaprakasan, K. (2026). L26/O-032 Clinical outcomes following non-invasive preimplantation genetic testing in IVF: A systematic review and meta-analysis. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.032
Vancouver
Kovilveettil A, Abdulah A, Bailie E, Jayaprakasan K. L26/O-032 Clinical outcomes following non-invasive preimplantation genetic testing in IVF: A systematic review and meta-analysis. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.032
BibTeX
@article{Kovilveettil2026,
author = {Kovilveettil, A.N. and Abdulah, A. and Bailie, E. and Jayaprakasan, K.},
title = {L26/O-032 Clinical outcomes following non-invasive preimplantation genetic testing in IVF: A systematic review and meta-analysis},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.032}
}
EUVIMED